Buy Torrent Pharmaceuticals; target of Rs 2700: Sharekhan
Sharekhan is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2700 in its research report dated January 05, 2024.08-01-2024
08-01-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation of Incorporation of wholly owned subsidiary04-01-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates02-01-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure u/r 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201530-12-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation Under regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201528-12-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Intimation of the Closure of Trading Window27-12-2023
Choice Broking's Sumeet Bagadia picks Torrent Pharma as top Christmas pick; here's why
Sumeet Bagadia of Choice Broking has chosen Torrent Pharma as his Christmas 2023 Pick'. Bagadia has recommended a Buy' on the pharma stock at 2,185 and up to 2,090 for a target price of 2,420 to 2,490.22-12-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of duplicate share certificates19-12-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Partial Redemption Of Non-Convertible Debentures
Partial redemption of NCDs issued under ISIN - INE685A0708214-12-2023
Torrent Pharma shares gain after US FDA completes inspection
The US FDA conducted a pre-approval inspection (PAI) at Torrent Pharmaceuticals' oral-oncology manufacturing facility12-12-2023